HCW Biologics Inc.

US$1.02As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:HCWBHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (73.81%)
Div yield —
ROE (151.36%)
Biotechnology
Beta (5Y) 2.27
PE TTM —
TSR TTM (95.61%)
Mkt cap US$2.281M
ROIC (37.30%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.06
3.68%
(21.00%)
Hold 12|2|9|12|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
16.44%
26.23%
25.23%
29.02%
Revenue$M
0.160
0.158
0.160
0.159
2.42%
(0.32%)
(1.02%)
(0.07%)
Peers (US$2.281M)
Cap (US$)
PE
2.349M
—
2.112M
—
2.312M
—
Capital
TTM
5Y
10Y
Leveragex
0.366
0.846
0.811
EBIT/Intx
2.460
0.242
0.217
Own earn%
(151.41)
129.82
124.81
Sh yield%
10.79
16.15
16.24
Owners
Insiders/Inst%
8.76
50.87
Short interest%
3.59
SBC / revenue%
5.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
28–31
$1 testx
−0.1
Incr. ROIC%
7